About Bristle
Bristle is a company based in San Francisco (United States) founded in 2020 by Shivam Patel. Bristle has raised $3.13 million across 2 funding rounds from investors including Initialized Capital, Y Combinator and Anne Wojcicki. The company has 7 employees as of December 31, 2022. Bristle offers products and services including Bristle Oral Health Test and The Oral Health Probiotic by Bristle. Bristle operates in a competitive market with competitors including Vigilant Biosciences, OralDNA, Oral3D, Incisive and Prebiomics, among others.
- Headquarter San Francisco, United States
- Employees 7 as on 31 Dec, 2022
- Founders Shivam Patel
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.13 M (USD)
in 2 rounds
-
Latest Funding Round
$3 M (USD), Seed
Jul 25, 2022
-
Investors
Initialized Capital
& 2 more
-
Employee Count
7
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bristle
Bristle offers a comprehensive portfolio of products and services, including Bristle Oral Health Test and The Oral Health Probiotic by Bristle.
Saliva-based test to analyze oral microbiome and identify health issues.
Probiotic to balance oral bacteria and improve conditions like gum inflammation.
People of Bristle
Unlock access to complete
Unlock access to complete
Funding Insights of Bristle
Bristle has successfully raised a total of $3.13M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $3 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Bristle
Bristle has secured backing from 3 investors, including venture fund and angel investors. Prominent investors backing the company include Initialized Capital, Y Combinator and Anne Wojcicki.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed and early-stage technology investments are managed by the firm.
|
Locked | Locked | Locked | |
|
Early-stage startups are accelerated via funding and educational programs.
|
Locked | Locked | Locked | |
|
AW
Anne Wojcicki |
Co-founder of 23andMe, prominent angel investor in health tech.
|
Locked | Locked | Locked |
Investor details for Bristle
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bristle
Investment portfolio details for Bristle
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bristle
Detailed financials for Bristle
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bristle Comparisons
Peer comparison for Bristle
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bristle
Bristle operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Vigilant Biosciences, OralDNA, Oral3D, Incisive and Prebiomics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Solutions for early oral cancer detection are developed and provided.
|
|
| Locked | Locked | Locked |
Saliva-based tests for periodontal disease and infections are developed.
|
|
| Locked | Locked | Locked |
Provider of a software for 3D printing for oral care
|
|
| Locked | Locked | Locked |
Porous enamel is detected and treated with a developed liquid.
|
|
| Locked | Locked | Locked |
Metagenomics technologies are provided for oral microbiome analysis kits.
|
Detailed competitors of Bristle
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bristle
Complete news archive for Bristle
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bristle
Bristle was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Bristle is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Bristle is a funded company, having raised a total of $3.13M across 2 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Bristle is 7.
Provider of dental treatment kits and dental health monitoring platform for individuals. The company collects saliva samples to get information on the risk of cavities and gum diseases to provide treatment plans to users. It has developed an app-based platform that allows users to access dental test questions based on oral health, lifestyle, and hygiene. The platform generates test reposts of the oral microbiome, shows the risk of any disease, and also allows monitoring of progress.
Bristle's top competitors include Vigilant Biosciences, OralDNA and Prebiomics.
Bristle offers Bristle Oral Health Test and The Oral Health Probiotic by Bristle.
Bristle has 3 investors. Key investors include Initialized Capital, Y Combinator, and Anne Wojcicki.